Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
reduces bone binding
ClH/c1-9-12(6-11(7-15)14(19)17-9)10-2-3-13-16-4-5-18(13)8-10
This agent also inhibits the expression of signaling kinases in the PI3K/Akt and MAPK/Ras signaling pathways and may result in cell cycle arrest and the induction of tumor cell apoptosis
Sub-optimal doses of 50 to 60 mg/kg CBL0137 hydrochloride causes similar enhancement of gemcitabine antitumor activity as that produced by the maximum tolerated dose (MTD) of 90 mg/kg as indicated by the lack of statistically significant differences among the combination groups
KNK437 Size:Contact [email protected] for quotation reduces bone bindingKNK437 is a HSP inhibitor, and inhibits the induction of HSP105, HSP70, and HSP40. Product information CAS Number: 218924 25 5 Molecular Weight: 245. 23 Formula: C13H11NO4 Chemical Name: (3E) 3 [(2H 1,3 benzodioxol 5 yl)methylidene] 2 oxopyrrolidine 1 carbaldehyde Smiles: O=C1 C( CCN1C=O)=C C1C=C2OCOC2=CC=1 InChiKey: LZGGUFLRKIMBDQ BJMVGYQFSA N InChi: InChI=1S C13H11NO4 c15 7 14 4 3 10(13(14)16)5 9 1 2 11 12(6 9)18 8 17 11 h1 2,5 7H,3 4,8H2 b10 5+
US$ 60.00
US$ 50.00
US$ 140.00
US$ 70.00
US$ 90.00
US$ 150.00